Joshua Muia on Genetic Alterations Affecting ADAMTS13 Maturation at IPS 2025
Joshua Muia, Associate Investigator at Versiti Blood Research Institute, shared on LinkedIn:
”It was an exciting week presenting work from laboratory at the International Proteolysis Society’s 13th Biannual Meeting in Buzios, Rio de Janeiro, Brazil.”
The International Proteolysis Society’s 13th Biannual Meeting , held in Búzios, Brazil, from October 26–30, 2025, offered an excellent opportunity for scholars and researchers to gather and engage in meaningful discussions on a wide range of topics.
The meeting also served as a valuable platform for networking and building important professional connections within the research community.
At the meeting Joshua Muia presented research from the Versiti Blood Research Institute laboratory on genetic alterations affecting ADAMTS13 maturation.
Stay updated with Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia